WASHINGTON – The Supreme Court on Monday declined to consider a patent dispute between biotech drug maker Amgen Inc. and two other companies involving Amgen’s blockbuster anemia drug Epogen. Despite passing on this case, justices have shown a heightened interest in patent law recently, taking up a half-dozen cases in the past two years and issuing two high-profile decisions in April. Amgen initiated the dispute in 1997 when it accused Aventis Pharmaceuticals Inc., a unit of Paris-based Sanofi-Aventis SA, and Shire Human Genetic Therapies Inc., a division of British drug developer Shire PLC, of infringing its patents on Epogen. Aventis was previously known as Hoechst Marion Roussel Corp. A federal district court largely agreed with Thousand Oaks-based Amgen’s claims, but the Court of Appeals for the Federal Circuit issued a mixed decision last year, ruling that two of Amgen’s patents were valid while reversing the lower court’s findings on two others. Amgen urged the Supreme Court to rule on the Federal Circuit’s practice of considering the factual record behind its patent claims, even though that record was also subject to thorough review at the district court level. Typically, appeals courts consider issues of law, rather than fact. The Federal Circuit’s willingness to reconsider the factual aspects of the case “produces incorrect results and causes litigants and district courts to waste tremendous resources,” Amgen said in its court filing. Amgen received $2.5 billion in revenue from Epogen sales in 2006. Last week, a Food and Drug Administration panel of outside experts recommended that the FDA require additional warnings on Epogen and two other anemia drugs, as well as additional tests on their safety. The news sent Amgen’s stock tumbling 9 percent Thursday and it remains more than 10 percent below its price before that announcement. Amgen’s shares fell 23 cents to $56.07 on Monday. 160Want local news?Sign up for the Localist and stay informed Something went wrong. Please try again.subscribeCongratulations! You’re all set!
A huge crowd is expected to run, jog and walk the Gaelscoil Adhamhnáin 5km at Glencar Letterkenny this evening, Thursday, at 7:30pm.This 5km is a tremendous opportunity for all those athletes, fun runners, joggers and walkers to test themselves on this new course. It is also a great warm up for the North West’s forthcoming flagship event of the year, the North West 10km.Registration is from 6:15 pm at Gaelscoil Adhamhnáin in Glencar, cost €8 runners, €5 walkers, €2 children, who must be accompanied by an adult. So come along and make it a family occasion.For more information see Facebook 5kgaelscoiladh and www.gaelscoiladhamhnain.com WARM UP FOR THE NORTH WEST 10K WITH GAELSCOIL 5K THIS EVENING was last modified: April 11th, 2013 by BrendaShare this:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Pocket (Opens in new window)Click to share on Telegram (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to share on Skype (Opens in new window)Click to print (Opens in new window) Tags:WARM UP FOR THE NORTH WEST 10K WITH GAELSCOIL 5K THIS THURSDAY